Half-year report · HY
7634.TEDINET S100X1C2
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥15.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥864m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥881m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥918m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥916m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥622m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥623m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥627m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥634m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥25.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥976m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥401m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥740m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.22 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥469.18 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.7 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥60m |
| Care Welfare Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥60,000 |
| Home Medical Treatment Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥431m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥651m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥614m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥92m |
| Medical Gas Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥283m |
| Nursing Homereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥2m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥804m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥864m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥62m |
| Care Welfare Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥20m |
| Home Medical Treatment Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥400m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥850m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥806m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥107m |
| Medical Gas Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥291m |
| Nursing Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥783,000 |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥819m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥881m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 500
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)泉 淳 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中 居 仁 良 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 7285705000 | JPY |
| Net sales (5-year summary) | InterimDuration | 7372926000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 15102329000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 924978000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 917594000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2052980000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 622897000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 622217000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1463492000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 791666000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 860086000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1543015000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 18053373000 | JPY |
| Net assets (5-year summary) | InterimInstant | 19466491000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 18715939000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 23618920000 | JPY |
| Total assets (5-year summary) | InterimInstant | 25389372000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 24590021000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 199.70 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 199.22 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 469.18 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.752 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.755 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.749 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 975823000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 1199800000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2189777000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -1313948000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -1031210000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -5284726000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -411855000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -400934000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -739640000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 9005764000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 5693473000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 5925818000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3420000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3420000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3420000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3420000 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 568000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.182 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |